Cross-sectional analysis reveals disparities in chlamydia and gonorrhea testing in males, highlighting racial differences.
BACKGROUND Racial differences in Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) testing and screening are well documented among adolescent females; however, data on adolescent males are limited. We sought to compare racial and ethnic differences in CT/GC testing and screening among adolescent males presenting to a pediatric emergency department (ED). METHODS Cross-sectional analysis of ED visits made by males aged 13 to 21 years at 2 urban pediatric hospital campuses between January 2021 to February 2023. The primary outcome was performance of CT/GC testing or screening. Multivariable logistic regression assessed racial and ethnic differences in CT/GC testing or screening, adjusting for age and ED site. RESULTS Among 17 244 ED visits, 643 (3.7%) included CT/GC testing or screening. Of the 473 (2.7%) visits by symptomatic males, 187 (39.5%) included CT/GC testing. Testing rates were higher in visits by non-Hispanic Black males compared with non-Hispanic white males (50.0% vs 11.8%; adjusted odds ratio [aOR], 3.3 [95% CI, 1.3–8.3]). Of the 16 771 visits by males with non-STI–related chief complaints, 456 (2.7%) included CT/GC screening. Screening rates were higher among visits by non-Hispanic Black males compared with non-Hispanic white males (3.5% vs 0.8%; aOR 3.1 [95% CI, 1.6–5.9]). CONCLUSIONS There were low rates of CT/GC testing overall; however, visits by non-Hispanic Black adolescent males were more likely to include both testing and screening compared with non-Hispanic white males. More research is needed to determine possible cause of this racial difference and to identify strategies to mitigate potential racial differences in CT/GC testing in the ED.
No takes yet. Share an insight, caveat, or question.
Rolin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: